Milestone Scientific Inc. Stock Sees Dramatic After-Hours Surge
Milestone Scientific Inc. (NYSE: MLSS) experienced an impressive surge of 35.67% in after-hours trading, bringing its stock price up to $0.52. This surge follows the release of the company's latest quarterly earnings, showcasing reduced operational costs and narrowing losses.
Third Quarter Earnings Highlights
In its recent earnings announcement, Milestone Scientific outlined a substantial decrease of over $500,000 in operating expenses compared to the same quarter of the previous year. This strategic cost-cutting has significantly improved the firm's financial health.
Operational Loss and Net Loss Improvement
The firm reported an operating loss that decreased by 23%, totaling approximately $1.1 million, compared to the prior year when the loss was $1.5 million. Additionally, the net loss improved, now reported at $1.2 million or $0.01 per share, in contrast to $1.5 million or $0.02 per share during the same quarter last year.
Revenue Performance Overview
Revenue for Milestone Scientific hovered around $2.4 million for the third quarter, which is a slight drop from the $2.5 million recorded in the same period last year. A decrease in domestic dental sales was noted, however, this was countered by a rise in international dental demand and steady recurring medical revenue. Over the first nine months of the current year, revenues rose by 5% to reach $6.9 million, driven by growth in international markets and increasing recurring revenues in the medical sector.
CEO's Perspective on Future Growth
CEO Eric Hines expressed optimism regarding the increasing use of CompuFlo functionalities and their corresponding disposable revenues. This, according to him, indicates a positive trend towards the product's adoption in medical settings.
Advancements in Reimbursement Strategies
Milestone Scientific is advancing its reimbursement strategy, which hinges on recent adjustments in Medicare payment rates and an expansion of commercial insurance coverage. These factors are likely to enhance acceptance and utilization of their medical devices within the healthcare ecosystem.
Current Stock Performance Analysis
Despite the recent uptick, Milestone Scientific's stock has seen a 59.61% decline year to date. The stock's range over the last year has been between $0.35 and $1.39, and the company's market capitalization stands at roughly $29.8 million.
Market Sentiment and Future Prospects
Analyzing the stock's performance, reports indicate that MLSS stock is currently experiencing a negative price trend across various time frames. Investors remain cautious as the previous volatility could affect future performance.
Frequently Asked Questions
What caused the recent surge in Milestone Scientific's stock?
The significant price increase was primarily driven by the company's announcement of improved earnings and reduced operational costs.
How much did operational expenses decrease in the third quarter?
Milestone Scientific reported a reduction of over $500,000 in operating costs compared to the same period last year.
What is the current revenue for Milestone Scientific?
The company's third-quarter revenue was approximately $2.4 million, slightly down from last year's $2.5 million.
What is CEO Eric Hines's take on the company’s performance?
He has expressed encouragement regarding the upward trend in sales and the adoption of their main medical device.
What is the stock performance trend for Milestone Scientific?
The company has seen a significant decline of 59.61% in its stock value year to date, despite the recent after-hours rise.
